Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males

Clinical Nutrition

Volumn 23, Issue 5, 2004, Pages 1084-1095

  Markovic, Olivera ^a   O'Reilly, Gillian ^a   Fussell, Helen M ^b,c   Turner, Stephen J ^b,c   Calder, Philip C ^a   Howell, William M ^b,c   Grimble, Robert F ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cytokines; Fish oil; Gene polymorphisms; IL 1 ; IL 6; LT ; TNF

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID; ANTILIPEMIC AGENT; CYTOKINE; FISH OIL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; LYMPHOTOXIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ALLELE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIET RESTRICTION; DRUG MECHANISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NORMAL HUMAN; OBESITY; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; ALLELES; BODY MASS INDEX; FASTING; FISH OILS; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544289819     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2004.02.002     Document Type: Article

References (71)

1. Tracy R.P. Lemaitre R.N. Psaty B.M. et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 17 1997 1121-1127
2. Koenig W. Sund M. Frohlich M. et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the monica (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237-242
3. Festa A. D'Agostino R. Jr. Williams K. et al. The relation of body fat mass and distribution to markers of chronic inflammation Int J Obes Relat Metab Disord 25 2001 1407-1415
4. Yamada S. Gotoh T. Nakashima Y. et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: jichi medical school cohort study Am J Epidemiol 153 2001 1183-1190
5. Pannacciulli N. Cantatore F.P. Minenna A. Bellacicco M. Giorgino R. De Pergola G. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women Int J Obes Relat Metab Disord 25 2001 1416-1420
6. Mendall M.A. Patel P. Ballam L. Strachan D. Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study BMJ 312 1996 1061-1065
7. Frohlich M. Imhof A. Berg G. et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 23 2000 1835-1839
8. Kazumi T. Kawaguchi A. Hirano T. Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol Metabolism. 52 2003 1113-1116
9. Hotamisligil G.S. Shargill N.S. Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87-91
10. Hotamisligil G.S. Arner P. Caro J.F. Atkinson R.L. Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J Clin Invest 95 1995 2409-2415
11. Mohamed-Ali V. Goodrick S. Rawesh A. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo J Clin Endocrinol Metab 82 1997 4196-4200
12. Kopp H.P. Kopp C.W. Festa A. et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients Arterioscler Thromb Vasc Biol. 23 2003 1042-1047
13. Tamakoshi K. Yatsuya H. Kondo T. et al. The Metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state Int J Obes Relat Metab Disord. 27 2003 443-449
14. Forouhi N.G. Sattar N. McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians Int J Obes Relat Metab Disord 25 2001 1327-1331
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801-809
16. Haffner S.M. Insulin resistance, inflammation, and the prediabetic state Am J Cardiol 92 2003 18J-26J
17. Hak A.E. Pols H.A. Stehouwer C.D. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the rotterdam study J Clin Endocrinol Metab 86 2001 4398-4405
18. Weyer C. Yudkin J.S. Stehouwer C.D. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians Atherosclerosis 161 2002 233-242
19. Samra J.S. Summers L.K.M. Frayn K.N. Sepsis and fat metabolism Br J Surg 83 1996 1186-1196
20. Carpentier Y.A. Jeevanandam M. Robin A.P. et al. Measurement of glycerol turnover by infusion of isotopic glycerol in normal and injured subjects Am. J. Physiol 247 1984 E405-E411
21. Gallin J.I. Kaye, D, O'Leary W.M. Serum lipids in infection N Engl J Med 281 1969 1081-1086
22. Roche H.M. Gibney M.J. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism Am J Clin Nutr 71 1 Suppl 2000 232S-237S
23. Chan D.C. Watts G.F. Mori T.A. Barrett P.H. Redgrave T.G. Beilin L.J. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity Am J Clin Nutr. 77 2003 300-307
24. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies Am J Clin Nutr 65 1997 1645S-1654S
25. Wong S. Reardon M. Nestel P. Reduced triglyceride formation from long-chain polyenoic fatty acids in rat hepatocytes Metabolism 34 1985 900-905
26. Willumsen N. Skorve J. Hexeberg S. Rustan A.C. Berge R.K. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis Lipids 28 1993 683-690
27. Halminski M.A. Marsh J.B. Harrison E.H. Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver J Nutr 121 1991 1554-1561
28. Gronn M. Christensen E. Hagve T.A. Christophersen B.O. Effects of dietary purified eicosapentaenoic acid (20: 5 (n-3)) and docosahexaenoic acid (22: 6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells Biochim Biophys Acta. 1125 1992 35-43
29. Jump D.B. Clarke S.D. Thelen A. Liimatta M. Ren B. Badin M. Dietary polyunsaturated fatty acid regulation of gene transcription Prog Lipid Res. 35 1996 227-241
30. Nossen J.O. Rustan A.C. Gloppestad S.H. Malbakken S. Drevon C.A. Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes Biochim Biophys Acta. 879 1986 56-65
31. Calder P.C. n-3 polyunsaturated fatty acids and cytokine production in health and disease Ann Nutr Metab 41 1997 203-234
32. Grimble R.F. Dietary lipids and the inflammatory response Proc Nutr Soc 57 1998 535-542
33. Calder P.C. Zurier R.B. Polyunsaturated fatty acids and rheumatoid arthritis Curr Opin Clin Nutr Metab Care 4 2001 115-121
34. Belluzzi A. Brignola C. Campieri M. et al. Effect of an enteric coated fish oil preparation on relapses in Crohn's disease N Engl J Med 334 1996 1557-1616
35. Mayser P. Mrowietz U. Arenberger P. et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double blind, randomized, placebo-controlled, multicenter trial J Am Acad Dermatol 38 1998 539-547
36. Endres S. Ghorbani R. Kelley V.E. et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells N Engl J Med 320 1989 265-271
37. Schmidt E.B. Varmig K. Moller J.M. et al. No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans Scand J Clin Lab Med 56 1996 87-92
38. Blok W.L. Deslypere J.P. Demacker P.N. et al. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year Eur J Clin Invest 27 1997 1003-1008
39. Meydani S.N. Lichtenstein A.H. Cornwall S. et al. Immunologic effects of National cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment J Clin Invest 92 1993 105-113
40. Molvig J. Pociot F. Worsaae H. et al. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals Scand J Immunol 34 1991 399-410
41. Meydani S.N. Endres S. Woods M.M. et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women J Nutr 121 1991 547-555
42. Caughey G.E. Mantzioris E. Gibson R.A. et al. The effect on human tumor necrosis factor alpha and interleukin-1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil Am J Clin Nutr 63 1996 116-122
43. Yaqoob P. Pala H.S. Cortina-Borja M. et al. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions Eur J Clin Nutr 30 2000 399-410
44. Gallai V. Sarchielli P. Trequattrini A. et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids J Neuroimmunol 56 1995 143-153
45. Kelley D.S. Taylor P.C. Nelson G.J. et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in healthy men Lipids 34 1999 317-324
46. Grimble R.F. Howell W.M. O'Reilly G. et al. The ability of fish oil to suppress tumor necrosis factor-alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes which influence TNF-alpha production Am J Clini Nutr 76 2002 454-459
47. Bouma G. Crusius J.B.A. Ouderk Pool M. et al. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA alleles Scand J Immunol 43 1996 456-463
48. Wilson A.G. di Giovine F. Duff G.W. Genetics of tumour necrosis factor-α in autoimmune, infectious and neoplastic disease J Inflam 45 1995 1-12
49. Warzocha K. Ribeiro P. Bienvenu J. et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 91 1998 3574-3581
50. Burzotta F. Iacoviello L. Di Castelnuovo A. et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization Am J Cardiol 88 2001 1125-1128
51. Terry C.F. Loukaci V. Green F.R. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation J Biol Chem. 275 2000 18138-18144
52. Santtila S. Savinainen K. Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro Scand J Immunol 47 1998 195-198
53. Fossati P. Prencipe L. Serum triglycerides determined colourimetrically with an enzyme that produces hydrogen peroxide Clin Chem 28 1982-2077
54. Wilkins J. Gallimore J.R. Moore E.G. Pepys M.B. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein Clin Chem 44 1998 1358-1361
55. Wilkins J. Gallimore J.R. Tennent G.A. et al. Rapid automated enzyme immunoassay of serum amyloid A Clin Chem 40 1994 1284-1290
56. Miller D.A. Dykes D.D. Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acid Res 16 1988-1215
57. Stuber F. Petersen M. Bokelmann F.A. Genomic polymorphisms within the tumor necrosis factor locus influences plasma TNF-α concentrations and outcome of patients with sepsis Crit Care Med 24 1996 381-384
58. Read R.C. Camp N.J. di Giovine F.S. et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease J Infect Dis 182 2000 1557-1560
59. Kroeger K.M. Steer J.H. Joyce D.A. Abraham L.J. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism Cytokine 12 2000 110-119
60. Fishman D. Faulds G. Jeffery R. et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369-1376
61. Howell W.M. Bateman A.C. Turner S.J. Theaker J.M. Influence of TNF-α and LT-α single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population Eur J Immunogenet 29 2002 17-23
62. Howell W.M. Turner S.J. Theaker J.M. Bateman A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma Eur J Immunogenet 30 2003 409-414
63. McCarron S.L. Edwards S. Evans P.R. et al. The CRC/BPG UK Familial Prostate Cancer Study Collaborators, Easton DF, Eeles RA, Howell WM. Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 2002 3369-3372
64. McGuire W. Hill A.V. Allsopp C.E. Greenwood B.M. Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria Nature 371 1994 508-510
65. Schroder J. Kahlke V. Book M. Stuber F. Gender Differences in sepsis: genetically determined? Shock. 14 2000 307-310
66. Nemetz A. Toth M. Garcia-Gonzalez M.A. et al. Variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases Gut 49 2001 644-649
67. Takamatsu M. Yamauchi M. Maezawa Y. Saito S. Maeyama S. Uchikoshi T. Genetic Polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients Am J Gastroenterol 95 2000 1305-1311
68. Burger D. Dayer J.M. High-density Lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 1-2 2002 111-117
69. Mendall M.A. Patel P. Ballam L. Strachan D. Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study BMJ 312 1996 1061-1065
70. Koenig W. Sund M. Frohlich M. et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the monica (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992 Circulation 99 1999 237-242
71. Ciubotaru I. Lee Y.S. Wander R.C. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT J Nutr Biochem 14 2003 513-521